Results 271 to 280 of about 1,191,145 (307)
Some of the next articles are maybe not open access.
[Carbohydrate antigen CA 19-9: value in pancreatic pathology].
Gastroenterologie clinique et biologique, 1986In order to determine the diagnostic usefulness of the dosage of carbohydrate antigen (CA 19-9) serum levels in pancreatic diseases, 38 patients with pancreatic lesions proved at laparotomy were studied. Pancreatic lesions were classified into two groups: a) group I: pancreatic adenocarcinoma (17 cases) b) group II: benign pancreatic diseases (21 cases)
J, Venot +5 more
openaire +1 more source
19-9 carbohydrate antigenic determinant (CA 19-9): a tool for digestive cancer diagnosis ?
1987info:eu-repo/semantics ...
Amir, Roland +3 more
openaire +1 more source
Bulletin du cancer, 1986
In order to ascertain the clinical usefulness of CA 19-9 in detecting pancreatic cancer in comparison with CEA, and to verify the influence of age and liver dysfunction on serum levels of these two antigens, serum CA 19-9 and CEA were assessed in 32 control subjects, 32 patients with pancreatic cancer, 26 with chronic pancreatitis and 43 with ...
DEL FAVERO, GIUSEPPE +8 more
openaire +2 more sources
In order to ascertain the clinical usefulness of CA 19-9 in detecting pancreatic cancer in comparison with CEA, and to verify the influence of age and liver dysfunction on serum levels of these two antigens, serum CA 19-9 and CEA were assessed in 32 control subjects, 32 patients with pancreatic cancer, 26 with chronic pancreatitis and 43 with ...
DEL FAVERO, GIUSEPPE +8 more
openaire +2 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
The clinical utility of the CA 19-9 tumor-associated antigen.
The American journal of gastroenterology, 1990Since Koprowski and coworkers discovered the CA 19-9 antigen 10 yr ago, it has become the most useful blood test in the diagnosis and management of patients with cancer of the pancreas. With an upper limit of normal of 37 U/ml, the assay's overall sensitivity is approximately 80% and its specificity is 90%.
openaire +1 more source
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1996
L, Fernández-Fernández +4 more
openaire +2 more sources
L, Fernández-Fernández +4 more
openaire +2 more sources
Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
The Italian journal of surgical sciences, 1985CA 19-9 and CEA serum levels were determined before and 7 days after surgery in 140 patients with gastrointestinal adenocarcinoma, and in 70 patients with gastrointestinal non neoplastic diseases. CA 19-9 test was shown to be positive in 37.9% of colorectal cancer, in 32.6% of gastric cancer and in 77.8% of pancreatic cancer.
MENNINI, Giuseppe +7 more
openaire +2 more sources
CA 19-9 and Lewis Antigens in Pancreatic Cancer
Journal of Clinical Oncology, 2009openaire +2 more sources
A guide to antigen processing and presentation
Nature Reviews Immunology, 2022Novalia Pishesha +2 more
exaly